ALLMedicine™ Autoimmune Hepatitis Center
Research & Reviews 2,875 results
https://doi.org/10.1080/14656566.2021.1895747
Expert Opinion on Pharmacotherapy; Chung Y, Rahim MN et. al.
Feb 24th, 2021 - Autoimmune hepatitis (AIH) is an immune mediated, inflammatory disease affecting the liver as a result of environmental triggers in susceptible individuals leading to loss of self-tolerance. The immunopathogenesis of AIH is not fully understood wh...
https://doi.org/10.1016/j.aohep.2021.100321
Annals of Hepatology; Bessone F, Hernandez N et. al.
Feb 20th, 2021 - Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral he...
https://doi.org/10.1002/hep.31739
Hepatology (Baltimore, Md.); You Z, Li Y et. al.
Feb 8th, 2021 - The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. We report herein that CD69+ CD103+ CD8+ TRM cel...
https://doi.org/10.1111/petr.13978
Pediatric Transplantation; Hadley TA, Palle SK et. al.
Feb 1st, 2021 - Recurrent autoimmune hepatitis (rAIH) occurs in patients who undergo liver transplantation (LT) for AIH and de novo AIH (dAIH) is seen in patients who are transplanted for etiologies other than AIH. Whether these are distinct diseases with a simil...
https://doi.org/10.1007/s12016-021-08833-w 10.1056/NEJM199604043341406 10.1016/j.jhep.2015.03.005 10.1016/j.jhep.2004.08.002 10.1002/hep.1840070626 10.1016/0168-8278(95)80308-4 10.1016/S0140-6736(00)02166-8 10.1111/j.1478-3231.2011.02502.x 10.1053/j.gastro.2011.02.065 10.1016/S0016-5085(19)33223-8 10.1016/S0168-8278(99)80297-9 10.1002/hep.23584 10.1038/ajg.2015.139 10.1016/0168-8278(95)80226-6 10.1016/j.jhep.2005.06.006 10.1111/apt.13584 10.1016/j.jhep.2010.12.032 10.1111/apt.15157 10.1097/MCG.0b013e318154af74 10.1016/j.jhep.2004.01.009 10.1111/apt.12592 10.1002/hep.27983 10.1111/apt.15248 10.1016/j.jhep.2009.02.026 10.1159/000440752 10.1016/j.jhep.2014.10.018 10.14309/ajg.0000000000000538 10.1002/hep.25658
Clinical Reviews in Allergy & Immunology; Li Y, Yan L et. al.
Jan 29th, 2021 - Autoimmune hepatitis (AIH) is characterized by interface hepatitis, elevated serum alanine aminotransferase and aspartate aminotransferase levels, circulating autoantibodies, and elevated predominantly immunoglobulin G (IgG) levels. The goal in th...
Guidelines 5 results
https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2017&issue=01000&article=00013&type=Fulltext
The American Journal of Gastroenterology; Kwo,P.,et al
Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...
https://doi.org/10.1016/j.jhep.2015.06.030
Journal of Hepatology;
Sep 5th, 2015 - EASL Clinical Practice Guidelines: Autoimmune hepatitis.|2015| ,|therapeutic use,standards,drug therapy,
https://doi.org/10.1136/gut.2010.235259
Gut Gleeson D, Heneghan MA et. al.
Jul 15th, 2011 - Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease which, if untreated, often leads to cirrhosis, liver failure and death. Major advances were made in its management based on controlled trials performed in England and the USA in th...
https://www.aasld.org/sites/default/files/guideline_documents/autoimmunehepatitis2010.pdf
Michael P. Manns
May 31st, 2010 - Autoimmune hepatitis (AIH) is a generally unresolving inflammation of the liver of unknown cause. A working model for its pathogenesis postulates that environmental triggers, a failure of immune tolerance mechanisms, and a genetic predisposition c.
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.
May 31st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,
Clinicaltrials.gov 2,949 results
https://doi.org/10.1080/14656566.2021.1895747
Expert Opinion on Pharmacotherapy; Chung Y, Rahim MN et. al.
Feb 24th, 2021 - Autoimmune hepatitis (AIH) is an immune mediated, inflammatory disease affecting the liver as a result of environmental triggers in susceptible individuals leading to loss of self-tolerance. The immunopathogenesis of AIH is not fully understood wh...
https://doi.org/10.1016/j.aohep.2021.100321
Annals of Hepatology; Bessone F, Hernandez N et. al.
Feb 20th, 2021 - Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral he...
https://doi.org/10.1002/hep.31739
Hepatology (Baltimore, Md.); You Z, Li Y et. al.
Feb 8th, 2021 - The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. We report herein that CD69+ CD103+ CD8+ TRM cel...
https://doi.org/10.1111/petr.13978
Pediatric Transplantation; Hadley TA, Palle SK et. al.
Feb 1st, 2021 - Recurrent autoimmune hepatitis (rAIH) occurs in patients who undergo liver transplantation (LT) for AIH and de novo AIH (dAIH) is seen in patients who are transplanted for etiologies other than AIH. Whether these are distinct diseases with a simil...
https://www.medscape.com/viewarticle/945131
Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...
News 85 results
https://www.medscape.com/viewarticle/945131
Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...
https://www.medscape.com/viewarticle/930411
May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News
Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.
https://www.reuters.com/article/us-cymabay-nash/cymabay-therapeutics-scraps-two-studies-of-liver-drug-shares-plunge-idUSKBN1XZ1MC
Nov 25th, 2019 - (Reuters) - CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients, sending its shares down over 75%. The drug developer said it had obs...
https://www.mdedge.com/jcomjournal/article/211752/hepatology/study-links-hepatitis-higher-mortality-post-liver-transplant?channel=302
Richard Mark Kirkner
Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.
